Search

everythinglearnresearchcommunity

for

Search:↓

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Many Iraqi women with hirsutism also have hypothyroidism and acne.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

A man's baldness improved possibly due to a medication that blocks male hormones.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New treatments for hair loss are being developed using molecular biology.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Tailored combination therapy improves non-scarring alopecia outcomes.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.